A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Common Warts

Common Warts Clinical Trial

Official title:
A Randomized, Double-blind, Multi-center, Placebo-controlled, Dose-ranging, Efficacy and Safety Trial of a New Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) for Treatment of Common Warts (Verruca Vulgaris)

Status Completed

Clinical Trial Summary

Nonclinical studies have shown sandalwood oil to have anti-inflammatory, anti-fungal, antiviral, and anti-bacterial activities. Previous clinical studies have shown East Indian Sandalwood oil to be promising as a treatment for common warts in adults and children.

The primary objective of this study is to evaluate the efficacy and safety of 10%, 20%, and 30% East Indian Sandalwood Oil (EISO) ointment compared with the ointment placebo administered twice daily (bid) for 12 weeks for the treatment of common warts (Verruca vulgaris).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01286441
Study type	Interventional
Source	ViroXis Corporation
Contact
Status	Completed
Phase	Phase 2
Start date	November 2012
Completion date	June 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02798419` - Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts	Phase 2
Completed	`NCT02669862` - A Study of A-101 Solution in Subjects With Common Warts.	Phase 2
Active, not recruiting	`NCT02640820` - Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts)	Phase 2
Completed	`NCT02650466` - Nanopulse Efficacy Study for the Treatment of Common Warts	N/A
Not yet recruiting	`NCT03166137` - Carbon Dioxide Laser and Cryotherapy in Treatment of Warts	N/A
Completed	`NCT02748902` - Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands.	Phase 1